1. Introduction
   1. Market Introduction
   2. Market Research Methodology
      1. Research Process
      2. Primary Research
      3. Secondary Research     
      4. Data Collection Technique      
      5. Data Sources     
   3. Market Estimation Methodology
      1. Limitations of the Study
   4. Product Picture of Cancer Diagnostics
   5. Global Cancer Diagnostics: Classification
   6. Geographic Scope 
   7. Years Considered for the Study 
   8. Research Methodology in Brief  
   9. Parent Market Overview
   10. Overall Cancer Diagnostics Market Regional Demand
   11. Research Programs/Design       
   12. Market Breakdown and Data Triangulation Approach        
   13. Data Source
   14. Secondary Sources
   15. Primary Sources   
   16. Primary Interviews
   17. Average Primary Breakdown Ratio      
2. Market Dynamics
   1. Drivers
      1. Drivers
   2. Restraints
      1. Restraints
   3. Opportunity
      1. Impact forces on market dynamics  
      2. Impact forces during the forecast years     
   4. Industry Value Chain
      1. Upstream analysis       
      2. Downstream analysis   
      3. Distribution Channel    
      4. Direct Channel   
      5. Indirect Channel
   5. Potential Customers
   6. Manufacturing/Operational Cost Analysis
   7. Key Material Landscape
   8. Porter’s Analysis
      1. Supplier Power   
      2. Buyer Power
      3. Substitution Threat      
      4. Threat from New Entry 
      5. Competitive Rivalry      
   9. PESTEL Analysis 
      1. Political Factors  
      2. Economic Factor 
      3. Social Factors     
      4. Technological Factor     
      5. Environmental Factors 
      6. Legal Factor       
3. Global Cancer Diagnostics Market Segmentation, Revenue (USD Billion), (2024-2031)
   1. By Product Type
      1. Consumables
         1. Antibodies
         2. Kits & Reagents
         3. Probes
         4. Others
      2. Instruments
         1. Pathology-based Instruments
         2. Imaging Instruments
         3. Biopsy Instruments
   2. By Technology
      1. Imaging Testing
         1. Magnetic Resonance Imaging (MRI)
         2. Computed Tomography (CT)
         3. Positron Emission Tomography (PET)
         4. Others
      2. Biomarkers Testing
         1. Tumor Testing
         2. Genetic Testing
         3. Genomic Testing Or Genomic Profiling
         4. Others
      3. In Vitro Diagnostic Testing
         1. Polymerase Chain Reaction (PCR)
         2. In Situ Hybridization (ISH)
         3. Immunohistochemistry (IHC)
         4. Others
      4. Biopsy
         1. Needle biopsy
         2. Skin biopsy
         3. Endoscopic biopsy
         4. Others
   3. By Application
      1. Breast Cancer
      2. Lung Cancer
      3. Colorectal Cancer
      4. Melanoma Cancer
      5. Prostate Cancer
      6. Liver Cancer
      7. Others
   4. By End-User
      1. Hospitals and Clinics
      2. Diagnostic Laboratories
      3. Diagnostic Imaging Centers
      4. Research Institutes

4. Global Cancer Diagnostics Market Overview, By Region
   1.  North America Cancer Diagnostics Market Revenue (USD Billion), By Countries, (2024-2031)
      1.  US
         1. By Product Type
         2. By Technology
         3. By Application
         4. By End-User
      2. Canada
      3. Mexico
   2. Europe Cancer Diagnostics Market Revenue (USD Billion), By Countries, (2024-2031)
      1. Germany
      2. France        
      3. UK
      4. Spain
      5. Russia
      6. Italy
      7. BENELUX
   3. Asia Pacific Cancer Diagnostics Market Revenue (USD Billion), By Countries, (2024-2031)
      1.  China
      2.  Japan
      3.  Australia
      4.  South Korea
      5.  India
      6.  ASEAN
   4. Latin America Cancer Diagnostics Market Revenue (USD Billion), By Countries, (2024-2031)
      1.  Brazil
      2.  Argentina
      3.  Chile
   5. Middle East and Africa Cancer Diagnostics Market Revenue (USD Billion), By Countries, (2024-2031)
      1. GCC
      2. Turkey        
      3. South Africa
5. Global Cancer Diagnostics Market Revenue: Competitive Analysis, 2023
   1. Key strategies By players
   2. Revenue (USD Billion) and Market Share (%), By Manufacturers, 2023
   3. Player Positioning By Market Players, 2023
6. Competitive Analysis
   1. F. Hoffmann-La Roche Ltd. (Switzerland)
      1. Business Overview
      2. Business Financials (USD Billion)
      3. Product Category, Type, and Specification    
      4. Main Business/Business Overview
      5. Geographical Analysis
      6. Recent Development
      7. Swot Analysis
   2. GE Healthcare (United States)
   3. Thermo Fisher Scientific Inc. (United States)
   4. Siemens Healthineers (Germany)
   5. Abbott Laboratories (United States)
   6. Becton, Dickinson and Company (United States)
   7. Qiagen N.V. (Netherlands
   8. Bio-Rad Laboratories, Inc. (United States)
   9. Illumina, Inc. (United States)
   10. Agilent Technologies, Inc. (United States)
7. Market Research Findings & Conclusion 

Disclaimer